Haemonetics To Present At The 18th Annual Morgan Stanley Global Healthcare Conference
Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 18th Annual Morgan Stanley Virtual Global Healthcare Conference on September 15, 2020, at 9:30 a.m. ET. The presentation will be accessible to the public via a live webcast and subsequent replay.
Haemonetics specializes in innovative hematology products aimed at enhancing patient care and reducing healthcare costs.
- None.
- None.
BOSTON, Sept. 9, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 18th Annual Morgan Stanley Virtual Global Healthcare Conference on Tuesday, Sept. 15, 2020, at 9:30 a.m. ET.
The public may access Mr. Simon's presentation live via webcast and subsequent replay at: https://morganstanley.webcasts.com/starthere.jsp?ei=1362373&tp_key=8d479de3b1
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contact:
Olga Guyette, Director-Investor Relations
(781) 356-9763
olga.guyette@haemonetics.com
Media Contact:
Carla Burigatto, VP- Global Communications
(781) 348-7263
carla.burigatto@haemonetics.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-the-18th-annual-morgan-stanley-global-healthcare-conference-301126923.html
SOURCE Haemonetics Corporation
FAQ
When is Haemonetics presenting at the Morgan Stanley Global Healthcare Conference?
How can I access the Haemonetics presentation?
Who is the CEO of Haemonetics Corporation?
What products does Haemonetics offer?